Close Menu

This article has been updated to note that there are close to 5,000 BRCA1/2 variants known to increase risk for breast and ovarian cancer. Additionally, based on information from Ancestry after the article's publication, the story now specifies that the NGS service when launched will conduct exome sequencing.

NEW YORK – Recreational genealogy firm Ancestry has partnered with Illumina and Quest Diagnostics to expand into health-related genetic testing. 

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.